ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Palliative and end-of-life care · Support Care Cancer · 2026-11-16

In a stepped wedge trial of 2348 distressed patients and caregivers calling a cancer telephone support service, structured distress screening and referral did not increase referral uptake or reduce distress versus usual care; intervention fidelity was poor.

RCTn = 2,348
Fradgley et al. The impact of structured care versus usual care on service uptake and distress among distressed callers to a cancer telephone support service: outcomes of the START stepped wedge trial
Palliative and end-of-life care · Support Care Cancer · 2026-11-09

Secondary analysis of an RCT in 189 patients with breast cancer: within true electroacupuncture, HTR3A rs909411 GG was linked to more complete protection from chemotherapy nausea and vomiting (62.3%) and COMT rs4633 to less; no SNP-by-treatment interaction.

Secondary analysisn = 189
Zheng et al. Association of HTR3A and COMT polymorphisms with electroacupuncture response for chemotherapy-induced nausea and vomiting in breast cancer: a secondary analysis of a randomized controlled trial
Palliative and end-of-life care · Support Care Cancer · 2026-10-23

Systematic review of 34 cohort studies (27,473 patients with gastrointestinal cancers): cachexia was associated with postoperative complications (OR 1.38) and longer hospital stay (MD 2.09), not chemotherapy adverse events (OR 1.42, NS). Very low certainty evidence.

Meta-analysisn = 27,473
Furuya et al. Association between cancer cachexia and treatment-related adverse outcomes in patients with gastrointestinal cancers: a systematic review and meta-analysis
Palliative and end-of-life care · Support Care Cancer · 2026-10-19

Network meta-analysis of 12 RCTs (736 cancer patients): prolonged scalp hypothermia (>90 min) improved hair preservation vs usual care (RR 24.66; 95% CI 7.07–86.05) and traditional cooling (RR 2.13), but not significantly vs short. Low to very low certainty.

Meta-analysisn = 736
Boonpattharatthiti et al. Comparative efficacy of interventions for preventing chemotherapy-induced alopecia: a systematic review and network meta-analysis
Palliative and end-of-life care · Support Care Cancer · 2026-10-10

In 132 patients with breast cancer and sleep disturbance on chemotherapy, 12 weeks of anti-inflammatory dietary education vs usual care lowered PSQI (β −2.10) and sleep disturbance at 12 weeks (49.2% vs 78.9% in 116 completers), and improved quality of life.

RCTn = 132
Cheng et al. Effects of anti-inflammatory dietary education on sleep disturbances among patients with breast cancer undergoing chemotherapy: A randomized controlled trial
Palliative and end-of-life care · Support Care Cancer · 2026-09-28

In a 3-arm RCT of 66 cancer caregivers, both cognitive behavioural stress management and acceptance and commitment therapy improved quality of life and fatigue versus control (CBSM's QoL gain not kept at 2 months), with no significant difference between the two therapies.

RCTn = 66
Hosseini et al. A comparison of the efficacy of cognitive-behavioral stress management and acceptance and commitment therapy on the quality of life and fatigue of caregivers of patients with cancer: a randomized controlled trial
Palliative and end-of-life care · Support Care Cancer · 2026-09-23

In a phase 2 randomised dose-finding study of oral NEPA in 65 evaluable children receiving highly or moderately emetogenic chemotherapy, overall complete response was 70.6% with netupitant 1.33 mg/kg and 67.7% with 4 mg/kg; no new safety signals were seen.

RCTn = 65
Patel et al. A phase 2 pharmacokinetic and pharmacodynamic dose-finding study of oral NEPA for chemotherapy-induced nausea and vomiting in pediatric patients with cancer
Palliative and end-of-life care · Support Care Cancer · 2026-09-19

Meta-analysis of 39 RCTs (8399 adults with cancer): early palliative care (within 12 weeks of diagnosis or first-line treatment) versus standard care improved quality of life (SMD 0.30); an exploratory survival benefit was seen (HR 0.84), to be interpreted with caution.

Meta-analysisn = 8,399
Long et al. Integration of early palliative care in cancer treatment: a meta-analysis of 39 randomized controlled trials on clinical outcomes and management optimization

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.